To the Editor: I concur with Professor Stockigt’s recent article1 outlining the shortcomings of product information (PI) for thyroid-related drugs. I often need to contradict incorrect or even hazardous PI advice given to patients.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA.
Correspondence: dtorpy@mail.rah.sa.gov.au
- 1. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
- 2. MIMS. myDr.com.au. Consumer medicine information. Hysone. http://www.mydr.com.au/drugs/cmi.asp?cmicode=2098&prodcode=068201 (accessed Mar 2007).
- 3. Stewart PM. The adrenal cortex. In: Reed Larsen P, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology. 10th ed. WB Saunders, 2003: 531-532.
- 4. MIMS. myDr.com.au. Consumer medicine information. Cortate. http://www.mydr.com.au/drugs/cmi.asp?cmicode=2496&prodcode=067201 (accessed Mar 2007).
- 5. Dowden JS. Product information past perfect [editorial]. Med J Aust 2007; 186: 51-52. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.